Position in PYXS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$101,359
New position
Shares Held
69,424
first reported quarter
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 78 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026PANAGORA ASSET MANAGEMENT INC holds $504,243,073 across 65 Biotechnology names. PYXS ranks #61 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,210,909 | $113,970,755 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105,225 | $81,301,044 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
742,117 | $55,109,608 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
461,193 | $28,916,801 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
143,499 | $27,128,485 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
351,370 | $23,938,838 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
592,912 | $17,615,415 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
57,320 | $17,022,320 |
All Filings in PYXS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $101,359 | 69,424 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||